HealthIT Answers April 18, 2023
By Tom Dorsett, CEO, RazorMetrics
Twitter: @razormetrics
As of April 2023, the FDA has approved the use of 40 “biosimilars”, which are a less expensive version of an advanced “biologic” medication. The rise of biosimilars is a major source of excitement as a way to control rising drug costs. But is the fervor warranted?
The Rise of Biologics and Biosimilars
Biologics are aptly named as they are actually biological medicines made from living organisms, a relatively new pathway to treat difficult diseases. They are more expensive than traditional drugs because the manufacturing process is highly technical, requires different material sources, are structurally more complex, and have more regulatory requirements.
Currently, the most effective and popular treatment for arthritis is a biologic...
Today's Sponsors
Today's Sponsor